🔬 The India Immunoglobulin Market is projected to expand from US$ 347 million in 2024 to US$ 1,220.6 million by 2033, with a robust CAGR of 15.00% (2025–2033). 📈 Growth is driven by rising prevalence of immunodeficiency disorders, increased availability of plasma-derived therapies, stronger government support, and growing domestic manufacturing. 🇮🇳 Increased health awareness and wider therapy access are also fuelling market momentum. 🔗 https://www.renub.com/india-immunoglobulin-market-p.php #India 🇮🇳 #Immunoglobulin 💉 #Healthcare 🏥 #Biopharma 🔬 #Therapeutics 💊 #CAGR 📈 #MarketGrowth 🚀 #Immunodeficiency 🌿 #PlasmaTherapy 🧬 #MedicalInnovation 💡 #PharmaIndustry